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by Elsevier B.V. This is an open accesAbstract Background and objectives: The flexible bronchoscope has become widely used by
pediatric pulmonologists as a diagnostic and therapeutic tool. Nevertheless, there are several
gaps in our knowledge to help refine its use and reduce its complications. In this study, we
aimed to evaluate the utility and complications of pediatric bronchoscopy.
Design and setting: We conducted a retrospective review of bronchoscopy cases between
March 2006 and April 2015 at a tertiary care medical center (King Fahad Medical City). One-
hundred forty nine patients were studied.
Patients and methods: We evaluated how bronchoscopy contributed to the patients’ diagnosis,
assessed the accuracy of bronchoalveolar lavage white blood cell count (BAL WBC) to differen-
tiate between infectious and non-infectious conditions, assessed the ability of clinical factors
to predict high risk of desaturation during bronchoscopy, and finally summarized the reported
procedural complications.
Results: We found pediatric bronchoscopy was a crucial diagnostic (confirming, ruling out, and
discovering unexpected diagnosis) and therapeutic tool. The accuracy of BAL WBC counts is
poor (AUC (95% CI) Z 0.609 (0.497e0.712)); however, using two cutoff values (10 WBCs
(sensit iv ity Z 84.44% and specificity Z 29.27%) to rule out, and 400 WBCs
(sensitivity Z 33.33% and specificity 81.49%) to rule in infection) helped in early differentia-
tion between infectious and non-infectious conditions. From the factors that we test, none
we found predictive of desaturation. The most common procedural complication waspital, Riyadh, Saudi Arabia. Tel.: þ966 530458314.
mail.com (R.S. Terkawi).
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Flexible bronchoscopy in children 19desaturation (pooled incidence (95% CI) Z 13 (8e19)%) followed by cough, mild airway
bleeding, and spasm.
Conclusions: Flexible bronchoscopy is an important and relatively safe diagnostic and thera-
peutic tool in pediatric medicine, and utilization of this service should be encouraged after
a careful consideration of which patient needs this procedure and a rigorous estimate of its
pros and cons.
Copyright ª 2016, King Faisal Specialist Hospital & Research Centre (General Organization),
Saudi Arabia. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The flexible fiber optic bronchoscope, a real revolution in
the management of respiratory diseases, was first intro-
duced into pediatric care in 1978 [1], long time after Ger-
many first reported the use of a rigid bronchoscope in 1897
to remove a foreign body from an adult [1]. Subsequent to
its introduction, the flexible bronchoscope has been widely
used as both a diagnostic and therapeutic tool [1,2].
In general, bronchoscopy aids in the visualization of the
airway anatomy (e.g., agenesis), the assessment of airway
dynamics (e.g., malacia), in the localization and treatment
of obstructions (e.g., mucus plugs), obtaining fluid samples
(i.e., bronchoalveolar lavage (BAL)), and brushing/biopsy
for microbiology and histopathology. Additional therapeutic
indications consist of suctioning, re-inflation, therapeutic
wash out, administration of medication, and guidance for
difficult intubation [1e8].
Bronchoscopy is an invasive procedure that requires
anesthesia in children. It carries some risk of complications
such as desaturation, airway trauma, and laryngeal spasm
[2,5]. Several gaps in our knowledge remain, especially
regarding ways to improve diagnostic capabilities and
minimize complications [9,10]. Consequently, further
studies to reach these objectives are warranted.
In this study, we aimed to: (1) investigate the usefulness
of the pediatric flexible bronchoscope in our practice; (2)
assess the accuracy, sensitivity, and specificity of white cell
count (WBC) in BAL for detecting infectious conditions; (3)
determine the rate of complications of this procedure; and
(4) delineate the risk factors/predictors for desaturation
during the procedure to avoid this serious complication.
2. Patients and methods
This is a retrospective review of records of children (under
14 years old) who underwent flexible bronchoscopy by a
single pulmonologist (A.A) at King Fahad Medical City,
Riyadh, Saudi Arabia, between March 2006 and April 2015.
2.1. Anesthesia care and procedure monitoring
Written consents were taken from all families after
explaining the pros and cons of the bronchoscopy proce-
dure. The majority of procedures were conducted under
general anesthesia with a muscle relaxant, either rocuro-
nium or succinylcholine at the discretion of the attendinganesthesiologist, except for cases of suspected malacia
where the patient was consciously sedated initially to
facilitate diagnosis. Patients with suspected malacia were
typically underwent conscious sedation, mainly with inha-
lational anesthetics, followed by intubation and general
anesthesia as indicated. Once malacia was identified, the
procedure was continued under general anesthesia. Anes-
thesia was maintained with volatile anesthetics (without
nitrous oxide) for procedures in the operating theater and
with total intravenous anesthesia with propofol, mid-
azolam, and fentanyl for procedures in the pediatric
intensive care unit. Routine anesthesia monitoring included
pulse oximetry, capnography, temperature, three-lead
electrocardiogram, and non-invasive blood pressure moni-
toring. All patients were instructed to have nil per os (NPO)
for at least 6 h before anesthesia while intravenous fluids
were given for maintenance.
When lidocaine was used intra-operatively, intravenous
fluids were continued after the procedure and patients
were kept NPO for 2 h. In this case, vital signs (including
oxygen saturation, respiratory rate, and pulse rate) were
measured every 5 min and then every 15 min when the
patient was awake. If lidocaine was not used, patients were
given an oral diet as tolerated.
2.2. Medications used and procedure technique
We used normal saline in all lavage cases. Lidocaine (1% or
2% solution, whichever was available, at a dose of 1e2 mg
per kg) was used either on the vocal cords or carina to
minimize cough and bronchospasm. Hypertonic saline,
acetylcysteine, and/or recombinant human deoxyribonu-
clease (dornase-alfa) were used in collapsed lung lobes to
re-channelize airways. Albuterol inhaler and IV dexameth-
asone were used during prolonged intervention to minimize
airway constriction. Epinephrine was also used for a patient
with a hemorrhagic airway.
Bronchoalveolar lavage (BAL) was performed in patients
with suspected respiratory infection to determine the
offending microbe, as well as in cases of suspected hemo-
siderosis, lipoid pneumonia, alveolar proteinosis, and in
cases of unclear diagnosis, in addition to therapeutic use to
re-channelize airways. The location and extent of BAL
depended on the disease. For localized lesions, BAL was
performed only in the affected lobe, while with diffuse
disease it was performed in the right middle lobe and
lingual lobe with or without the anterior/lateral segments
of the lower lobes.
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warmed to body temperature. A volume of 3 ml/kg was
calculated and administered in three divided doses in
children less than 20 Kg. In children weighing more than
20 Kg, 20 ml volumes were injected using a syringe via the
suction channel of the bronchoscope. Approximately
40e70% of fluids were recovered by suction using a pressure
of 25e100 mmHg as recommended by the European Society
for Clinical Respiratory Physiology [11]. BAL fluids were
transported to the laboratory in isolated bags containing
ice, or at body temperature if processing was performed
within 30 min (in emergency settings). All procedures were
performed with an Olympus pediatric flexible fiber optic
bronchoscope (BF-XP260F; Olympus America; Melville, NY,
USA). As in most paediatric bronchoscopy centers, we used
two sets of 2.8 mm sized bronchoscopes, which is the
smallest size with a suction channel [8]. No biopsies were
taken during any of the procedures. An automated counting
method for cell counts and differentials was used.
2.3. Data extraction and synthesis
With the Institutional Review Board approval, we collected
a predetermined data set from children who underwent
flexible bronchoscopy at King Fahad Medical City during the
above indicated time period. Extracted data included: age,
gender, indication (pre-bronchoscopy diagnosis), post-
bronchoscopy diagnosis, medications used during the pro-
cedure, observed complications associated with the pro-
cedure, location of the procedure in the hospital, and the
patient’s immune status. Complete blood count (CBC)
within 24 h before the procedure, BAL WBC counts, bac-
terial, fungal, and mycobacterium cultures, polymerase
chain reaction (PCR) results for detection of viruses were
also collected. Histopathology reports were reviewed
whenever applicable.
We included tracheooesophageal fistula and trache-
omalacia in one category, as the former is a leading cause of
tracheomalacia in approximately 75% of patients, and
10e20% will have significant tracheomalacia [12]. In our
practice, we use bronchoscopy to evaluate tracheomalacia
more often than to diagnose fistulas because fistulas can be
diagnosed by other non-invasive tests such as barium
studies. Malacia of different levels and etiologies (except
malacia secondary to tracheooesophageal fistula) were
placed in the same category because many of these patients
have diffuse or multiple levels of malacia, and all of them
have non-specific clinical manifestations. Therapeutic BAL
for each disease was merged with its disease in Table 1.
Post-bronchoscopy diagnosis was based on visualization
of the airway in certain conditions. For instance, lower
airway infection/inflammation was diagnosed when the
airway was noted to be erythematous or swollen or to have
dilated vessels or mucopurulent secretions.
To create a comprehensive picture of pediatric bron-
choscopy complications, we performed a PubMed search
using the following terms (“bronchoscopy” and “pediatrics”
and “complications”), without any limitation on the date of
publication or language. Two authors (RST and AST)
screened the articles and conducted the data extraction
independently. Disagreements were resolved by consensus.2.4. Statistical analysis
We first assessed the data for normality using the
ShapiroeWilk test. Normally distributed data are presented
as the mean and standard deviation (SD), while non-
normally distributed are presented as the median with
the first and third interquartile [IQR]. Categorical data are
presented as frequency and percentage.
We used the Receiver Operating Characteristics (ROC)
curve to detect the accuracy (as area under the curve
(AUC)) of WBC count in BAL in differentiating between in-
fectious and non-infectious causes and to select the best
cut-off values. AUC values were divided into four ranges;
0.61e0.70, 0.71e0.80, 0.81e0.90, and 0.91e1, indicating
poor, fair, good, and excellent levels of accuracy, respec-
tively [13].
We assessed the agreement between the pre- and post-
bronchoscopy diagnoses using Kappa statistics. The values
of Kappa were divided into three ranges; 0.41e0.60,
0.61e0.80, and 0.81e1, indicating moderate, substantial,
and almost perfect agreements, respectively [14]. The
agreement value reflects how the bronchoscopy procedure
changed the diagnosis.
We looked for possible risk factors that led to desatu-
ration during bronchoscopy using logistic regression [15].
The tested predictors/risk factors were age (continuous
and categorical; less than one year, from one to five years,
and more than five years), gender, weight, the location of
the procedure (e.g., pediatric ICU vs. operating theater),
airway access route (e.g., endotracheal tube, tracheos-
tomy tube), BAL performed (yes or no), pre-procedure and
post-procedure diagnoses, and the presence of infection.
These factors were determined a priori based on clinical
experience and previous reports [6,16].
Finally, we summarized the incidence of reported com-
plications in different studies using pooled-effect estimates
and corresponding 95% confidence intervals that were
derived using a random-effects model that incorporates
between-study variability [17].
A P-value of .05 was considered significant. SPSS soft-
ware version 21 (SPSS, Chicago, IL) was used for most an-
alyses. MedCalc Statistical Software version 15.2.2
(MedCalc Software bvba, Ostend, Belgium; http://www.
medcalc.org; 2015) was used for the ROC and pooled inci-
dence analyses.
3. Results
One hundred sixty patients who underwent flexible bron-
choscopy were considered for this study. Eleven were
excluded due to missing significant data. The remaining one
hundred and forty-nine patients were included. Seventy-
five (50.3%) were males, and 74 (49.7%) were females. Their
median [IQR] age was 27 [9.5,60] months, ranging from
12 days and 14 years. The majority of the bronchoscopy
procedures were performed in the operating theaters 74.5%
(n Z 111) followed by the pediatric ICU 24.8% (n Z 37).
Only one procedure was performed in the cardiac cathe-
terization laboratory.
An endotracheal tube was the major airway access
device (82%), followed by a face mask (9%), nose (7%), and
Table 1 Pre- and post- bronchoscopy diagnoses.
Indication (suspected pre-bronchoscopy diagnosis) Post-bronchoscopy diagnosis
Suspected lower airway infections (n Z 73) 41.2% 61 LAWa infection/inflammation
5 Malaciab
2 Airway H/A, MP or Plastic B.c
2 Normal airway
1 Foreign body
1 Pulmonary hemorrhage
1 Lipoid pneumonia
Chronic stridor/wheezing (n Z 44) 24.9% 34 Malacia
4 LAW infection/inflammation
2 Normal airway
1 Airway H/A, MP or Plastic B.
1 Foreign body
1 Tracheooesophageal fistula
1 UA trauma, SS or VCPd
Persistent atelectasis/hypoplasia (n Z 24) 13.6% 11 Airway H/A, MP or Plastic B.
8 Malacia
3 LAW infection/inflammation
1 Normal airway
1 UA trauma, SS or VCP
Suspected TEFeysecondary malacia (n Z 14) 7.9% 8 Malacia
2 Normal airway
2 Tracheooesophageal fistula
1 LAW infection/inflammation
1 UA trauma, SS or VCP
Suspected foreign body (n Z 8) 4.5% 2 LAW infection/inflammation
2 Normal airway
2 Foreign body
1 Malacia
1 Airway H/A, MP or Plastic B.
Suspected airway trauma (n Z 3) 1.7% 2 Normal airway
1 LAW infection/inflammation
Suspected P.H.f/telangiectasia (n Z 3) 1.7% 3 Pulmonary hemorrhage
Suspected lipoid pneumonia (n Z 3) 1.7% 3 Lipoid pneumonia
Suspected pulmonary alveolar proteinosis (n Z 2) 1.1% 2 Alveolar proteinosis
Suspected pulmonary alveolar microlithiasis (n Z 1) 0.6% 1 Pulmonary microlithiasis
Suspected malignancy (n Z 1) 0.6% 1 LAW infection/inflammation
Summary of the indications: pre-bronchoscopy suspected diagnosis and post-bronchoscopy diagnosis, arranged from the most common to
the least common. For example, we had three patients who were suspected to have airway trauma: two were diagnosed after the
procedure to have normal airway, and one had LAW infection/inflammation.
a Lower airway.
b Tracheomalacia, bronchomalacia, laryngomalacia, and/or any malacia secondary to cardiac compression.
c Airway hypoplasia/agenesis, mucus plugs, or plastic bronchitis.
d Upper airway trauma, subglottic stenosis, or vocal cord paresis.
e Tracheooesophageal fistula.
f Pulmonary hemorrhage.
Flexible bronchoscopy in children 21tracheostomy tube (2%). The following medications were
used during the procedures: normal saline in 78% of the
procedures, lidocaine in 22%, hypertonic saline in 3%,
recombinant human deoxyribonuclease in 3%, acetylcys-
teine solution in 1%, albuterol in 1%, epinephrine in 1%, and
dexamethasone in 1%. Eleven percent of the procedures
were performed without medication.
The majority of the procedures were without compli-
cations 76% (n Z 113), while 22% (n Z 32) of the subjects
experienced desaturation (defined as transient drop in SpO2
below 90%), making this the most common complication. Allcases of desaturation were transient and were managed by
retracting the bronchoscope for a limited time to regain the
baseline saturation and then resuming the procedure.
These episodes were not accompanied by bradycardia or
hypotension. Other rare complications were vomiting
(n Z 1), laryngeal spasm (n Z 1), and apnea (n Z 1). The
patient who had apnea (for more than 1 min) was a
three-month-old infant. He was observed in the intensive
care unit for 24 h until he recovered his normal respiration
and was transferred back to the ward. We did not
encounter any serious adverse effects such as
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ported in other studies [6,18,19].
The majority of the patients were immune-competent
77% (n Z 114), while 23% (n Z 35) were immune-
compromised, 6% (n Z 8) had leukemia, 5% (n Z 7) were
neutropenic, 3% (n Z 4) had lymphoma, 2% (n Z 3) cystic
fibrosis, 2% (n Z 3) h Bare lymphocyte syndrome, 1%
(n Z 2) chronic granulomatous disease, and the remainder
of the patients (1% or n Z 1 for each condition) were
diagnosed with Chediak-Higashi syndrome, hypo-
gammaglobinaemia, primary ciliary dyskinesia (Kertaginer’s
syndrome), pancytopenia, severe combined immunodefi-
ciency (SCID), and hemophagocytic-lympho-histiocytosis
(HLH).
Table 1 summarizes the indications (suspected pre-
bronchoscopy diagnosis) for bronchoscopy, post-
bronchoscopy diagnoses, and explains their relationship.
The Kappa (SE) value of the agreement between the pre-
and post-bronchoscopy diagnosis was 0.58  0.04 indicating
moderate agreement.
BAL was performed in 70.5% (n Z 105) of patients.
Table 2 [20,21] summarizes the WBC counts and differen-
tials results from blood tests and BAL. We tested the ac-
curacy of the WBC count in the BAL in differentiating
between infectious and non-infectious/normal condition,
which was poor. The AUC (95% CI) was 0.61 (0.50e0.71)
(Fig. 1). Thus, it is impractical to rely on a single cut-off
value to differentiate (predict) between infectious and
non-infectious/normal conditions. We therefore selected
two cut-off values one with high sensitivity (to rule out) and
one with high specificity (to rule in) infection. We found
that a BAL WBC cut-off value of less than 10 WBCs had a
sensitivity of 84% (95% CI 71 to 94) and a specificity of 29%
(95% CI 16 to 46), while a value of more than 400 WBCs had
a sensitivity of only 33% (95% CI 20 to 49) but a specificity of
81% (95% CI 66 to 91).
One hundred and five BAL samples were processed for
culture and PCR. Fifty per cent were positive. Of the pos-
itive cultures/PCR, 32% (n Z 17) grew multiple organisms,
six of which were from immunocompromised patients. A
summary of the microbiological identification of the BAL is
presented in Table 3.
None of the covariates that were tested as possible risk
factors for desaturation in the logistic regression analysis
were significant. Tested variables were (age, weight,
gender, type of airway access, procedure location, BAL
obtained, presence of infection, suspected pre-procedure
diagnosis, post-procedure diagnosis).
Finally, to create a more comprehensive picture of po-
tential complications associated with pediatric flexible
bronchoscopy, we summarized our findings along with
those reported in previously published studies in Table 4
[22e26, 27].
4. Discussion
We tested the importance of the flexible bronchoscope as a
diagnostic tool in the pediatric population. We found only
moderate agreement (0.58  0.04) between the pre-
bronchoscopy suspected diagnoses and the
post-bronchoscopy confirmed diagnoses, which arguablyindicates an important role for bronchoscopy in determining
medical care in our practice (making the correct diagnosis).
Bronchoscopy was particularly helpful in identifying mala-
cia, foreign bodies, fistulas, traumas, and other diseases
simply by visualizing the airway. BAL helped in differenti-
ating between infectious and non-infections conditions
(mainly by providing samples for culture) and identify the
infective microbe in cases of respiratory infection. Thus,
adjustments of anti-microbial therapy were possible and
tailored according to microbial sensitivity. Targeting the
infective organism with narrow spectrum agents minimizes
the development of resistant organisms, which is becoming a
threatening issue globally [28]. As with BAL, brush samples
and biopsies for histopathology helped to identify some
uncommon diseases including lipoid pneumonia, alveolar
proteinosis, and pulmonary microlithiasis. Bronchoscopy was
not only important in confirming or ruling out a suspected
diagnosis, but more importantly, it was instrumental in
identifying unexpected diagnoses. For instance, two out of
four (50%) of the patients with a post-bronchoscopy diag-
nosis of foreign body aspiration were not suspected of hav-
ing this diagnosis prior to the procedure (Table 1). Patients
who had lipoid pneumonia, alveolar proteinosis, or pulmo-
nary microlithiasis had multiple procedures for therapeutic
purposes. Bronchoscopy was also useful not only in reaching
diagnoses and treating conditions, but it was instrumental in
gauging the severity of some conditions such as malacia
secondary to tracheooesophageal fistula or the degree of
airway obstruction by a foreign body or mucus plug.
We then tested the accuracy of the WBC count in BAL
(a routine test for most practitioners) in differentiating in-
fectious from non-infectious causes, which turned out to be
poor if a single cut-off value was used. To overcome this
limitation, we proposed two different cut-off values to help
the pulmonologist identify an infectious etiology with
reasonable confidence while waiting for the results of cul-
tures and histopathological stains that could take days to
weeks. About one-half of our study population had a respi-
ratory infection. Therefore, we compared cases of infection
with cases without infection in BAL WBC counts using a ROC
curve. Two cut-off values were considered, one with a high
sensitivity (to rule out) and other with a high specificity
(to rule in). The first cut-off value of less than 10 WBCs/mL
ruled out the respiratory infection in approximately 84% of
cases, and the second cut-off value of more than 400 WBCs/
mL ruled in respiratory infection in approximately 82% of
cases. Initiating antimicrobial therapy is still a matter of
contention when the diagnosis is still not clear. This decision
whether to initiate antibiotic therapy or not should be
balanced with other factors such as vital signs, general
condition, and other laboratory tests (e.g.: serum WBC
count and differentials) in addition to the results of BAL
WBC count.
We found that the yield of BAL culturesyPCR in our
center was 50%. Positive culturesyPCR were distributed
evenly between patients regardless of their immune status
and despite the fact that most of them received antibiotics
prior to bronchoscopy. This high yield of culturesyPCR
compared to those reported by other published studies [29]
may be explained by the nature of our patient mix, which
generally involved complicated cases with prolonged hos-
pitalizations that may have increased their chances of
Table 2 Summarizes the WBC counts and differential for each diagnosis in blood and bronchoalveolar lavage for patients with a single diagnosis.
Post-bronchoscopy diagnosis Blood (serum) Bronchoalveolar lavage
Total WBC
counta
Neutrophils
percentage
Lymphocytes
percentage
Monocytes
percentage
Eosinophils
percentage
Total WBC
countb
Neutrophils
percentage
Lymphocytes
percentage
Monocytes
percentage
Eosinophils
percentage
Macrophages
percentage
LAWc infection/inflammation
(n Z 70)
9.4
[5.5,14.3]
50.4
[30.6,68]
36.3
[20.9,50]
7.6
[4.3,11.6]
1
[0.4,2.8]
180
[24.5,531]
67
[37.3,87]
12
[5.5,24.5]
6.5
[3,13.8]
2
[1,5.5]
40
[1.5,80]
Bacterial infection (n Z 25) 9.8
[7.8,15]
51.2
[38.2,63.6]
37.2
[22.8,49.7]
8.2
[4.6,11.9]
1.6
[0.4,3.6]
343
[64.5,1584]
80
[41.5,90.5]
12
[5,27.5]
3.5
[2,9.3]
2
[2,3]
3
[0,NA]
Mixed infection (n Z 6) 10.6
[1.1,20.8]
38.6
[20.7,88.5]
42.4
[6.6,62.5]
7.6
[6.3,22.5]
1.2
[0.1,5.3]
486
[25,3612]
82
[44,97]
8.5
[2,28.8]
4
[1.5,5.5]
NA NA
Viral infection (n Z 5) 10.1
[3.1,21.9]
49.6
[39.1,64]
24.4
[23.7,44.7]
10.3
[7.5,24.9]
0.4
[0.3,2.9]
40
[17,187.5]
50
[34.5,75.5]
10
[4,20]
14
[8,21]
NA NA
Fungal infection (n Z 2) 5.5
[1, NA]
33.8
[0.4, NA]
10
[0.4, NA]
12.2
[11.4, NA]
11.9
[11.9,11.9]
NA NA NA NA NA NA
Infection with negative culture/
PCRd (n Z 32)
8
[2.6,13.8]
50
[22.7,78.4]
36.3
[20,67.8]
6
[3.1,10.4]
0.8
[0.5,2.6]
142
[10,360]
49
[13.5,82.3]
15.5
[8,24.8]
10
[5,19.5]
1
[1,8]
NA
Malaciae (n Z 29) 10.8
[9.2,13.5]
41.8
[33.8,65.8]
42.2
[28,53.2]
7.8
[4.5,11.4]
0.9
[0.3,2.1]
44
[18,1024]
65.5
[28,83.8]
30
[9,37.8]
16
[2.6,29.3]
5
[3, NA]
NA
Normal airway (n Z 16) 10.3
[7.5,16,8]
48.9
[22.5,69.5]
40.8
[23.4,64.6]
8.1
[3.3,10.2]
1.1
[0.2,1.9]
10.5
[4,443]
10
[8, NA]
35.5
[3, NA]
15.5
[1, NA]
NA NA
Airway hypoplasia/agenesis
(n Z 6)
8.5
[7,12.7]
24.4
[18.8,36]
62.1
[50.8,71.7]
8.2
[6.2,9.6]
0.5
[0,3.9]
90
[3, NA]
95
[59, NA]
4
[1, NA]
1
[1, NA]
NA NA
Lipoid pneumonia (n Z 4) 12
[7.5,13.7]
47.6
[31.3,69.8]
39.9
[19.8,46.4]
10
[6.3,13.7]
1.8
[0.1,11.4]
369.5
[181,634.5]
35
[11.5,63]
32.5
[12.5,66.8]
8
[5,17]
NA NA
Alveolar proteinosis (n Z 3) 8.4
[5.2, NA]
29.7
[27.7, NA]
50.3
[26.1, NA]
15.7
[8.2, NA]
2.9
[0.4, NA]
725
[450, NA]
NA NA NA NA NA
Data presented as median and 1st and 3rd [IQR].
a Total WBC count in 10e9/L.
b Total WBC count in cells/mL (micro liter).
c Lower airway.
d Negative cultures and polymerase chain reaction in bronchoalveolar fluid.
e Tracheomalacia, bronchomalacia, laryngomalacia, and/or malacia secondary to cardiac compression. NA Z Cannot be calculated
because of small sample size.
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Figure 1 Receiver operating characteristic (ROC) curve (dark
blue line) with its 95% CI (outer dashed blue lines) reflecting
the accuracy of the BAL WBC count to differentiate between
infectious and non-infectious conditions.
24 R.S. Terkawi et al.colonization and infection (as pseudomonas aeruginosa was
the most common pathogen). Contamination of samples is
another major issue that may affect laboratory outcomes,
even when using the most standardized techniques. As with
any other test, there is a risk of false positive/false nega-
tive results in BAL cultures/PCR. Currently, however, these
are the most accurate tools at our disposal. Nevertheless,
clinicians should consider the general condition of the pa-
tient and other laboratory tests to obtain an integrated
view of the accuracy of any given results.
We tested multiple potential demographic and clinical
risk factors to identify patients with a greater risk for
desaturation during the procedure. However, none was
significant. It would be helpful to know which patients and
conditions might carry a greater risk of this common
complication to allow for special precautions (e.g., doing
the procedure in operating theater with a more specialized
pediatric anesthesiologist). Studies by Schnapf’s and Peng’s
found that younger patients are more susceptible to desa-
turation [6,16]. Schnapf’s study reported that patients be-
tween six and 12 months are more susceptible to
desaturation, while Peng et al mentioned that desaturation
occurred more often in small infants without mentioning
the age. Finally, though it would be helpful to assess how
the skill of the pulmonologist impacts the occurrence of
desaturation during bronchoscopy, this was not possible in
our study because a single operator performed all pro-
cedures. Nonetheless, having the entire cohort managed byTable 3 A summary of the microbiological identification from t
Category Micro-organisms
Bacteriay23.5% (n Z 35) Pseudomonas aeruginosa
Acinetobacter baumannii
Escherichia coli
Staphylococcus aureus
Enterobacter cloacae
Streptococcus pneumoniae
Haemophilus influenzae
Stenotrophomonas
maltophilia
Delftia acidovorans
Klebsiella pneumoniae
Klebsiella oxytoca
Streptococcus intermedius
Streptococcus salivarius
Streptococcus milleri
Streptococcus viridans
Kluyvera ascorbata
Moraxella catarrhalis
Mycobacterium species (not m
Pseudomonas putida
Virusesy7.4% (n Z 11) Cytomegalovirus (CMV)
EpsteineBarr virus (EBV)
Herpes simplex virus (HSV)
Fungiy4.7% (n Z 7) Candida albicans
Aspergillus flavus
Yeast, not candida
Due to the presence of more than one organism that grew from the BAL
100%.a single operator allowed for control for this potential
cofounder while assessing the other possible risk factors.
We found also that recombinant human deoxyribonu-
clease (dornase-alfa) is useful in patients with atelectasis.
We used it in four patients with aliquots of 2.5 mg injectedhe BAL.
Number (n Z 53) Percentage
21 39.6%
6 11.3%
4 7.5%
4 7.5%
4 7.5%
3 5.7%
3 5.7%
3 5.7%
2 3.8%
2 3.8%
1 1.9%
1 1.9%
1 1.9%
1 1.9%
1 1.9%
1 1.9%
1 1.9%
. tuberculosis) 1 1.9%
1 1.9%
7 13.2%
3 5.7%
1 1.9%
3 5.7%
3 5.7%
1 1.9%
cultures from the same patient, percentages add up to more than
Table 4 Comparison between complications within different studies.
Authors and number
of patients
Desaturation Mild bleeding/
epistaxis
Laryngeal/bronchial
spasm
Coughing Hypotension Apnea Subglottic
Edema
Vomiting
Our study (n Z 149)
Saudi Arabia; 2015
21.5%
(n Z 32)a
0.7%
(n Z 1)
0.7%
(n Z 1)
0.7%
(n Z 1)
0.7%
(n Z 1)
Peng et al [6] (n Z 725)
Taiwan; 2011
0.8%
(n Z 6)
Woodhull et al [22] (n Z 216)
Singapore; 2010
13.4%
(n Z 29)
1.9%
(n Z 4)
Malherbe et al [23] (n Z 52)
Canada; 2010
19%
(n Z 10)
27%
(n Z 14)
21%
(n Z 11)
Tang et al [24] (n Z 53)
China; 2009
20.8%
(n Z 11)a
3.8%
(n Z 2)
1.9%
(n Z 1)
Righini et al [25] (n Z 82)
France; 2007
2.4%
(n Z 2)
2.4%
(n Z 2)
Manna et al [10] (n Z 148)
UK; 2006
10.8%
(n Z 16)
17%
(n Z 25)
Rodrı´guez et al [26] (n Z 66)
Colombia; 2003
27.3%
(n Z 18)b
6.1%
(n Z 4)
Sa´nchez et al [21] (n Z 700)
Chile; 2003
2.7%
(n Z 19)
0.7%
(n Z 5)
Nussbaum [5] (n Z 2836)
USA; 2002
0.7%
(n Z 21)c
4%
(113)
0.6%
(n Z 17)
De Blic et al [27] (n Z 1382)
France; 2002
2.6%
(n Z 36)d
0.5%
(n Z 6)
0.9%
(n Z 13)
1.9%
(n Z 26)
Wong et al [20] (n Z 141)
Taiwan; 1995
3.5%
(n Z 5)
0.7%
(n Z 1)
De Blic et al [3] (n Z 37)
France; 1991
70.3%
(n Z 26)e
Puhakka et al [7] (n Z 1032)
Finland; 1987
10.8%
(n Z 77)
2.1%
(n Z 16)
Total
(n Z 7620)
3.9%
(n Z 300)
1.6%
(n Z 122)
0.9%
(n Z 65)
0.6%
(n Z 44)
0.3%
(n Z 25)
0.2%
(n Z 13)
0.03%
(n Z 2)
0.01%
(n Z 1)
Pooled incidence
(95% CI) per 100 patientsf
13
(8e19)
2
(0.2e5.4)
1
(0.7e1.4)
9.3
(0.6e26.6)
NA 4.7
(0.04e16.7)
NA NA
NA Z not applicable.
a Desaturation defined in our study and in Tang’s study as a transient drop in SpO2 (Hemoglobin Oxygen Saturation) below 90%.
b Desaturation defined in Rodrı´guez’s study as a drop in SpO2 below 10% or more from baseline.
c Desaturation defined in Nussbaum’s study as a drop in SpO2 65%e80%.
d Desaturation defined in De Blic’s study at 2002 as a drop in SpO2 below or equal 90%.
e Desaturation defined in De Blic’s study at 1991 as a transient drop in SpO2 not less than 80%.
f We used a random-effects model to account for heterogeneity between studies, data represents the incidence (percentage) with (95%
CI). There was no significant heterogeneity in cough; however, we still reported the random-effects model result, both random and fixed-
effects estimates for cough were almost identical.
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26 R.S. Terkawi et al.directly in the airways of the affected lobe. Marked bron-
choscopic, radiological and even clinical improvements
were observed. Although we do not have a control group for
comparison and cannot be certain that the improvement
was due to dornase-alfa and not to simple suctioning or
infusion of normal saline, the efficacy of this medication
has been reported in couple of case-reports, and we used it
on trial basis [30e32].
Bronchoscopy, like all invasive procedures, has its pros
and cons. It carries the risk of complications from the
inserted bronchoscope, extensive lavage, and anesthetic
medications. In our study, 24% of patients developed non-
life-threatening complications. The most common was
transient desaturation. We summarized the complications
associated with pediatric bronchoscopy that have been re-
ported in the literature to determine a global, comprehen-
sive estimation. A good understanding of procedural
complications can better prepare for appropriate patient
management as well as aid in counseling parents. Consistent
with our findings, desaturation was the most common re-
ported complication. Previous authors have used widely
variable reductions in SpO2 to define desaturation leading to
significant heterogeneity. For instance, Nussbaum et al [5]
defined desaturation as a drop in SpO2 to 65%e80%, Rodrı´-
guez et al [26] defined it as a drop in SpO2 of 10% or more
below the baseline, while still other studies did not define
the term at all. We used a random-effects model to over-
come this issue. It is important to realize that desaturation in
children is particularly dangerous and can rapidly cause
bradycardia and even cardiac arrest. Therefore, prompt
response and precise coordination and cooperation between
the pulmonologist and anesthesiologist are essential.
Contrary to the findings in our study, cough reflex was a
significant complication reported by Malherbe et al [23] and
Rodrı´guez et al [26]. The difference is likely because we
used a muscle-relaxing agent during the procedures. Mal-
herbe et al [23] suggested that the use of remifentanil can
decrease the incidence of cough during the procedure.
Similarly, Nicolai et al [9] suggested that deep sedation/
anesthesia can mitigate the cough reflex when muscle
relaxation is undesirable.
Airway bleeding during bronchoscopy is another known
complication. In this cohort, we encountered only one pa-
tient who developed minor bleeding. This patient had a
diagnosis of pulmonary hemosiderosis, and epinephrine was
used to control bleeding.
Of note, post-bronchoalveolar lavage fever is a reported
complication in some studies [6,11,33]. While the origin of
this fever is unknown, it is transient and more common in
children less than two years old [33]. In our cohort, there
were no reports of new fevers following bronchoscopy.
Our study has some limitations including the relatively
small sample size and the retrospective design. This might
affect some of our results, in particularly those related to
WBC count accuracy in BAL and the risk factors for desa-
turation. We, therefore, recommend further studies with a
larger number of patients to identify and address these
issues more conclusively.
In conclusion, the flexible bronchoscope is a valuable tool
in the diagnosis and treatment of airway disorders in children.
It has a good safety profile with rarely reported life threat-
ening or longstanding complications. Furthermore, the abilityto perform BAL with this procedure can play a significant role
in the early differentiation of conditions due to infection
versus thoseunrelated to infection, and aids in identifying the
exact pathology and best treatment. Earlier intervention and
utilization of bronchoscopy should be encouraged after a
careful consideration of which patients would benefit from
this procedure and a rigorous estimate of its pros and cons.
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